Sequential Compression Device for Asthenia

Phase-Based Progress Estimates
Mayo Clinic Jacksonville, Jacksonville, FL
Asthenia+2 More
Sequential Compression Device - Device
All Sexes
What conditions do you have?

Study Summary

The primary purpose of this study is to establish that application of a Sequential Compression Device (SCD) and lower extremity (LE) sleeve applied to a hemi-paretic upper extremity is safe.

Eligible Conditions

  • Asthenia
  • Stroke

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

7 Primary · 0 Secondary · Reporting Duration: 4 hours

4 hours
Edema measured in inches of circumference of forearm
Nail Bed Color
Pain with SCD Sleeve and device
UE Sensation
UE Strength using Motor Arm subsection #5 of NIH scale
UE skin integrity
Wearing tolerance of the SCD and sleeve on the upper extremity.

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Sequential Compression Device (SCD) on upper extremity
1 of 1
Experimental Treatment

20 Total Participants · 1 Treatment Group

Primary Treatment: Sequential Compression Device · No Placebo Group · N/A

Sequential Compression Device (SCD) on upper extremity
Experimental Group · 1 Intervention: Sequential Compression Device · Intervention Types: Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 4 hours
Closest Location: Mayo Clinic Jacksonville · Jacksonville, FL
Photo of jacksonville mayo clinic 1Photo of jacksonville mayo clinic 2Photo of jacksonville mayo clinic 3
2005First Recorded Clinical Trial
1 TrialsResearching Asthenia
107 CompletedClinical Trials

Who is running the clinical trial?

Mayo ClinicLead Sponsor
2,860 Previous Clinical Trials
3,686,141 Total Patients Enrolled
Suzanne Langley, OTPrincipal InvestigatorMayo Clinic

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are admitted to Mayo Clinic/Jacksonville, post-stroke with a hemiparetic upper extremity.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.